A leading pharmaceutical company faced the challenge of managing multilingual regulatory and clinical documentation to support operations in Europe, Africa, and Asia. Entrusting White Globe, the Medical Affairs team sought precise and compliant translations for diverse needs across regions. White Globe commenced with translating regulatory submission documents, including Common Technical Documents (CTDs) and Marketing Authorisation Applications (MAAs), into 15 languages. This ensured seamless approvals from international regulatory bodies. Clinical trial protocols, informed consent forms, and investigator brochures were localised, enabling effective multinational trial execution and participant engagement. To uphold patient safety, White Globe translated Patient Information Leaflets (PILs), package inserts, and pharmacovigilance reports into culturally sensitive and linguistically accurate formats, ensuring patients and healthcare providers had clear, actionable information. Educational materials, including training manuals and e-learning modules, were localised for healthcare professionals, enhancing understanding of new drug therapies. Extending support to marketing efforts, White Globe tailored health economics reports and promotional content to resonate with global stakeholders, facilitating robust market access strategies. Through precision, compliance, and cultural alignment, White Globe empowered the pharmaceutical leader to expand its global footprint, championing safety and innovation in the healthcare sector.
To request a copy of the case study, please email sales@whiteglobe.co.in

A global pharmaceutical leader partnered with White Globe to overcome multilingual challenges in medical translation, ensuring compliance and accessibility for operations across Europe, Africa, and Asia. The Medical Affairs team required precise translations for regulatory documents, patient education materials, and clinical trial content to meet stringent industry standards and regional requirements. White Globe began by translating regulatory submission documents, including Common Technical Documents (CTDs) and Marketing Authorisation Applications (MAAs), into multiple languages to streamline drug approvals in diverse markets. Clinical trial protocols, patient consent forms, and investigator brochures were localised to support multinational trials and enhance participant understanding. To empower patient safety, White Globe translated package inserts, Patient Information Leaflets (PILs), and pharmacovigilance documents into region-specific languages, ensuring clarity in dosage instructions and adverse event reporting. Educational materials for healthcare professionals, including e-learning modules and training manuals, were meticulously adapted to suit linguistic and cultural nuances. White Globe’s expertise extended to localising marketing collaterals and health economics documents, enabling the pharmaceutical company to resonate with global stakeholders. By delivering timely, accurate, and culturally aligned translations, White Globe fortified the client’s commitment to innovation, safety, and accessibility in the pharmaceutical industry.
To request a copy of the case study, please email sales@whiteglobe.co.in